KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2025)

Recursion Pharmaceuticals (RXRX) has disclosed Tax Rate for 3 consecutive years, with 0.02% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 1.0% year-over-year to 0.02%, compared with a TTM value of 0.02% through Dec 2025, down 22.0%, and an annual FY2025 reading of 0.02%, down 22.0% over the prior year.
  • Tax Rate was 0.02% for Q4 2025 at Recursion Pharmaceuticals, down from 0.0% in the prior quarter.
  • Across five years, Tax Rate topped out at 4.19% in Q4 2023 and bottomed at 0.17% in Q3 2024.
  • Average Tax Rate over 3 years is 0.68%, with a median of 0.04% recorded in 2025.
  • The sharpest move saw Tax Rate plummeted -419bps in 2024, then rose 17bps in 2025.
  • Year by year, Tax Rate stood at 4.19% in 2023, then tumbled by -100bps to 0.0% in 2024, then tumbled by -373bps to 0.02% in 2025.
  • Business Quant data shows Tax Rate for RXRX at 0.02% in Q4 2025, 0.0% in Q3 2025, and 0.08% in Q1 2025.